PHÂN TÍCH TÌNH HÌNH ĐIỀU TRỊ NỘI TRÚ CHO NGƯỜI BỆNH TĂNG HUYẾT ÁP TẠI BỆNH VIỆN LÊ VĂN THỊNH NĂM 2024

Abstract

Objectives: This study was conducted to investigate the inpatient treatment patterns for hypertensive patients at Le Van Thinh Hospital, thereby providing updated information to support periodic evaluations of hypertension treatment practices at the hospital.

Methods: A cross-sectional descriptive study was conducted through retrospective analysis of inpatient treatment data for hypertensive patients at Le Van Thinh Hospital in 2024.

Results: The study of 576 treatment episodes showed that females accounted for 64.4% and males for 35.6%. According to the JNC-7, 40.6% of patients had stage 2 hypertension, 4.3% had stage 1 hypertension, and 55.1% had primary hypertension. Amlodipine was the most commonly prescribed active ingredient (53.6%), followed by Captopril (44.1%), Bisoprolol (24.7%), Losartan (18.9%), and Telmisartan (13.4%). Most patients were prescribed between two to four active ingredients for hypertension during the treatment episode (67.5%). By drug class, calcium channel blockers were most frequently used (followed by angiotensin-converting enzyme inhibitors (55.2%), angiotensin II receptor blockers (45.8%), beta-blockers (31.9%), and diuretics (19.4%). Large amount of patients had comorbidities (89.8%) with dyslipidemia having the highest prevalence (86.1%). Patients with three or more comorbidities tended to have longer hospital stays.

Conclusion: The study results contribute to the development of guidelines and policies for more appropriate, safe, and effective hypertension medication use in the future. The study suggests the need for personalized treatment based on patient characteristics and comprehensive management of comorbidities to optimize treatment outcomes.